Search results
CAR T cell therapy for advanced prostate cancer demonstrates positive results in Phase I clinical...
Medical Xpress· 3 days agoThe trial treated 14 prostate stem cell antigen (PSCA)-positive patients who had metastatic castration resistant prostate cancer ...
The Unknowns Challenge Prostate Cancer Patient Partners
WebMD· 5 days agoProstate cancer has a huge impact on men. It’s the second most common cancer after skin cancer (an estimated 290,00 ...
Experts Focus on Quality-of-Life Data in Prostate Cancer
Medscape· 4 days agoSeveral trials presented at ASCO 2024 explored strategies to improve quality of life in patients with prostate cancer.
What do we know about Kate's cancer treatment?
BBC via AOL· 18 hours agoHow many people get cancer? In the UK, one in two people develop some kind of cancer during their lifetime. There are more than 200 different types of &...
Nicole Brown Simpson’s murder 30 years later: Where are OJ's children now?
Fox News via Yahoo News· 3 days agoAaren drowned in the family's swimming pool before her second birthday in 1979. Simpson died of ...
Radioligand therapy extends progression-free survival with manageable safety profile in advanced ...
Medical Xpress· 5 days agoNew data on prolonged prostate-specific antigen (PSA) progression and adverse events grouped by safety topic of interest from the PSMAfore study underscore the statistically ...
Cubs announce schedule for Ryne Sandberg statue dedication ceremony
Chicago Sun-Times· 2 days agoOn the 40th anniversary of the “Sandberg Game,” sportscaster Bob Costas will yet again speak Ryne...
Dr. Ravi Patel talks advancements in cancer treatments to prolong survival
KGET Bakersfield via Yahoo News· 5 days agoBAKERSFIELD, Calif., (KGET) — Much progress has been made in prolonging survival rates for cancer...
FAP-targeted therapy demonstrates significant efficacy in controlling advanced sarcomas
Medical Xpress· 5 days agoFibroblast activation protein (FAP)-targeted radioligand therapy is safe and effective for treating patients with progressive metastatic tumors, specifically advanced sarcomas ...
FDA Expands Repotrectinib Label
Medscape· 2 days agoThe new accelerated approval for the TKI was based on the overall response rate in 48 patients.